{"Title":"Calyxt","Industry":"AGRICULTURE CHEMICALS","Employees":"27","Founded":"","Address":"","Phone":"(651) 683-2807","Web_address":"http://www.calyxt.com","Market_cup":"$212.8mil","Revenues":"$.03 mil (last 12 months)","Net_income":"$-12.3 mil (last 12 months)","Symbol":"CLXT","Exchange":"NASDAQ","Shares":"7.0","Price_range":"$8.00 - $8.00","Est_volume":"$56.0 mil","Manager":"Citigroup/ Credit Suisse/ JefferiesWells/ Fargo Securities","CO_managers":"BMO Capital Markets/ Ladenburg Thalmann","Exp_to_trade":"7/20/2017","Status":"","Quiet_period":"Available only to Subscribers","Lock_up_period":"Available only to Subscribers","Scoop_rate":"Available only to Subscribers","Rating_change":"Available only to Subscribers","Business":"We are a consumer-centric, food- and agriculture-focused company. By combining our leading gene-editing technology and technical expertise with our innovative commercial strategy, we are pioneering a paradigm shift to deliver healthier food ingredients for consumers and agriculturally advantageous traits for farmers. We are developing and creating specialty food ingredients, such as healthier oils and high fiber wheat, and food crops with desirable traits, such as herbicide tolerance."}